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Introduction {#sec1}
============

Amyotrophic lateral sclerosis (ALS) is characterized by a loss of motor neurons in cortex, brain stem, and spinal cord with subsequent spasticity, muscle atrophy, and paralysis. Motor neurons innervating the extraocular muscles, including the oculomotor, trochlear, and abducens nuclei, are however relatively resistant to degeneration in ALS ([@bib8], [@bib14], [@bib30], [@bib31]). This resilience has been attributed to cell-intrinsic properties ([@bib2], [@bib6], [@bib7], [@bib19], [@bib22]). It would be highly advantageous if differential motor neuron vulnerability could be modeled *in vitro*. This could aid in the identification of gene targets responsible for oculomotor neuron resilience. However, it is not self-evident that *in vitro-*generated oculomotor neurons would be more resistant to degeneration in culture than spinal motor neurons, as multiple cell types contribute to motor neuron degeneration in ALS, including, for example, astrocytes ([@bib42]), microglia ([@bib5]), and oligodendrocytes ([@bib21]), and may play a role in selective vulnerability.

During development, distinct neuronal populations are defined through diffusible morphogens with restricted temporal and spatial patterns and subsequent activation of distinct intrinsic transcription factor programs. These programs can be mimicked to specify different CNS regions and neuronal populations from stem cells *in vitro*. When mouse embryonic stem cells (mESCs) are exposed to SHH (sonic hedgehog) signaling and retinoic acid, which ventralize and caudalize the CNS during development, spinal motor neurons constitute 15%--30% of the cells in culture, and interneurons the large remainder ([@bib3], [@bib41]). Oculomotor neurons constitute only about 1% of the cells in the midbrain; thus, patterning mESC cultures with fibroblast growth factor 8 (FGF8) and SHH to direct cultures toward a midbrain/hindbrain fate ([@bib3], [@bib20]) results in cultures with too few oculomotor neurons to allow for any quantitative analysis. However, when combining morphogens with overexpression of the intrinsic determinant *Phox2a* in neural precursors, a large proportion of ISLET1/2^+^ brain stem motor neurons can be generated ([@bib27]). Furthermore, a combination of the transcription factors *Ngn2*, *Isl1*, and *Phox2a* can specify mESCs into cranial motor neurons ([@bib26]). However, the exact identity of motor neurons generated this way has not been previously demonstrated, and it is currently unclear whether these are indeed oculomotor neurons or rather a mix of brain stem motor neurons, including, for example, trigeminal and facial motor neurons.

Toward the goal of developing stem cell-based *in vitro* models of differential vulnerability we generated cultures with a high proportion of oculomotor neurons through temporal overexpression of PHOX2A in mESC-derived neuronal progenitors and compared these with mESC-derived spinal motor neurons. Careful characterization of these distinct motor neuron populations using immunocytochemistry, electrophysiological recordings, and RNA sequencing demonstrated that mESC-derived oculomotor neurons were highly similar to their *in vivo* counterparts in both rodent and man. Finally, we exposed these to ALS-like conditions using kainic acid and demonstrated that oculomotor neurons were more resilient than spinal motor neurons. Thus, we can generate bona fide oculomotor neurons *in vitro* that display a resilience to ALS similar to that seen *in vivo*.

Results {#sec2}
=======

Bona Fide Oculomotor Neurons Can Be Generated from mESCs {#sec2.1}
--------------------------------------------------------

To characterize the specific identity of brain stem motor neurons generated in culture and compare their properties with those of spinal motor neurons, we generated neurons from mESCs. Spinal motor neurons were derived by adding 100 nM retinoic acid and the smoothened agonist SAG to the culture for 5 days. Brain stem motor neurons were specified by overexpressing *Phox2a* under the *nestin* enhancer and patterning the culture with FGF8 and SAG for 5 days ([Figure 1](#fig1){ref-type="fig"}A). Immunocytochemical analysis demonstrated that spinal motor neurons expressed the transcription factors ISLET1/2 and HB9 (MNX1) (64.1% ± 5.2% ISLET1/2^+^HB9^+^ cells, mean ± SEM, n = 4) ([Figures 1](#fig1){ref-type="fig"}B, 1D, and 1E). PHOX2A-overexpressing motor neurons appeared to be of an oculomotor identity as these cells expressed ISLET1/2 but lacked HB9 (6.3% ± 1.3% ISLET1/2^+^HB9^+^ cells, mean ± SEM, n = 4), which is present in all cranial motor neuron nuclei except the oculomotor nucleus ([Figures 1](#fig1){ref-type="fig"}C, 1D, 1F, and 1G) ([@bib15], [@bib24]). Henceforth we therefore refer to the brain stem motor neurons as oculomotor neurons. In oculomotor neuron cultures 47.5% ± 5.9% (mean ± SEM, n = 4) of βIII-TUBULIN^+^ cells were ISLET1/2^+^ and 62% ± 5.2% (mean ± SEM, n = 4) of the ISLET1/2^+^ cells were PHOX2A^+^, which demonstrates that 25% of all neurons generated were oculomotor neurons ([Figure 1](#fig1){ref-type="fig"}G).Figure 1PHOX2A Overexpression Drives the Generation of Bona Fide Oculomotor Neurons from Stem Cells(A) Time line depicting *in vitro* protocols for the generation of resistant oculomotor neuron (OMN) and vulnerable spinal cord motor neuron (SC MN). The mESC column reports the four cell lines used in this study. Patterning was performed for 5 days following EB formation. mRNA-seq coupled with FACS was performed on EB dissociation day (day 9 of the protocol). The survival assay was performed 5 days after EB dissociation (day 14 to 21).(B and C) SC MNs generated from E14.1 ESCs express HB9, ISLET1, and NF200 (B). OMNs generated from E14.1 ESCs overexpressing the transcription factor *Phox2a* under the *Nestin* enhancer co-express ISLET1 and NF200 in the absence of HB9 (C). Scale bar, 60 μm.(D) Percentage of HB9^+^/ISLET1^+^ cells in SC MN (64.1% ± 5.2%, mean ± SEM, n = 4) and OMN (6.3% ± 1.3%, mean ± SEM, n = 4) cultures, respectively (at least 120 Islet1^+^ cells counted per condition, bar and whiskers represent means ± SEM).(E) Microphotographs showing ISLET1^+^/TUJ1^+^ cells in OMN cultures.(F) OMNs also express the specific marker PHOX2A as indicated by asterisks. Scale bar, 100 μm (applies also to E).(G) Quantification of ISLET1^+^ over TUJ1^+^ cells demonstrates that half the neuronal population appears to be ISLET1^+^ (47.5% ± 5.9%, mean ± SEM, n = 4; total number of TUJ1^+^ cells counted: 1,325). Quantification of PHOX2A^+^ over ISLET1^+^ cells (experiments performed in quadruplicates with two technical replicates each, total number of Islet1^+^ cells counted: 746) indicates that 62% ± 5.2% (mean ± SEM, n = 4) of the ISLET1^+^ population is also PHOX2A^+^. All quantifications were performed 5 days after EB dissociation, and experiments were conducted in quadruplicates including two technical replicates per experiment (bar and whiskers represent means ± SEM).(H) PCA of OMN and SC MN samples based on all genes expressed confirmed cell differential identities. mRNA-seq analysis of OMNs and SC MNs isolated by FACS was performed after 5 days of patterning (day 9 of the protocol).(I) A total of 1,017 DEGs was found between the two different cell types (adjusted p \< 0.05, n = 6). Heatmap shows the top 500 most significant DEGs by adjusted p value.(J--L) Heatmap of expected progenitors and motor neuron transcripts but also OMN and SC MN specific transcripts obtained in the two generated motor neuron populations (J and L). Using the top 100 DEGs obtained from our RNA-seq analysis (K), we could separate datasets originating from *in vivo* microarray studies on early postnatal (J) and adult (L) rodent OMNs and SC MNs.(M and N) Venn diagrams showing gene sets enriched either in brain stem cultures or OMN-specific as revealed by PAGODA analysis (M), and gene sets preferentially found in spinal cord cultures or MN specific (N).

Oculomotor neurons (derived from Islet-GFP mESCs) and spinal motor neurons (derived from Hb9-GFP mESCs) were analyzed for their electrophysiological properties at day-9 and day-11 time points ([Figure S1](#mmc1){ref-type="supplementary-material"}). Cells were able to fire overshooting action potentials in response to depolarizing current pulses. At day 9 few spikes were evoked. Neuronal maturation from days 9 to 11 was seen as a change in the electrical properties whereby day-11 oculomotor neurons could fire trains of action potentials ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B) and the width of action potentials was decreased when compared to day 9 ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The increase in the size of neurons was reflected by the increased cell capacity ([Figure S1](#mmc1){ref-type="supplementary-material"}D), decreased input resistance ([Figure S1](#mmc1){ref-type="supplementary-material"}E), and increased rheobase ([Figure S1](#mmc1){ref-type="supplementary-material"}F) from days 9 to 11. Similar changes were seen in spinal motor neurons, which fired a higher number of action potentials ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H) and showed a reduced width of action potentials ([Figure S1](#mmc1){ref-type="supplementary-material"}I) at day 11 compared to day 9. Moreover, the changes in cell capacity ([Figure S1](#mmc1){ref-type="supplementary-material"}J), input resistance ([Figure S1](#mmc1){ref-type="supplementary-material"}K), and rheobase ([Figure S1](#mmc1){ref-type="supplementary-material"}L) showed signs of neuronal maturation over time. To further investigate neuronal maturation over time, we performed choline acetyltransferase (ChAT) staining on oculomotor and spinal motor neuron cultures, confirming expression of the transferase from day 14 *in vitro* in both ISLET1^+^/HB9^−^ and ISLET^+^/HB9^+^ cells ([Figures S1](#mmc1){ref-type="supplementary-material"}M and S1N).

To further confirm the identity of the cells generated, we sorted the motor neurons based on GFP expression using fluorescence-activated cell sorting (FACS). For this purpose we used a *Hb9*-GFP mESC line to select for spinal motor neurons and an *Islet*-GFP:*NesEPhox2a* mESCs line for the purification of oculomotor neurons ([Figures 1](#fig1){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A--S2D). Poly(A)-based RNA sequencing of the sorted fractions revealed a similar number of detected genes for both lines (reads per kilobase per million mapped reads \[RPKM\] \>0.1: oculomotor neurons 13,941 ± 293.5 and spinal motor neurons 14,660.3 ± 304.1; RPKM \>1: oculomotor neurons 10,507 ± 296 and spinal motor neurons 10,914.3 ± 362.7; mean ± SEM, t test for RPKM \>0.1 p = 0.1196, t test for RPKM \>1 p = 0.4047; [Figure S2](#mmc1){ref-type="supplementary-material"}E).

Sorted oculomotor neurons clustered closely together in the principal component analysis (PCA) and were separated from spinal motor neurons along the fourth principal component ([Figure 1](#fig1){ref-type="fig"}H). Hierarchical clustering of the 1,017 genes that were differentially expressed between oculomotor neurons and spinal motor neurons at an adjusted p value of \<0.05 demonstrated that each group is defined by a specific set of markers, with a majority of genes being more highly expressed in spinal motor neurons ([Figure 1](#fig1){ref-type="fig"}I and [Table S1](#mmc2){ref-type="supplementary-material"}). Analysis of Hox mRNAs clearly demonstrated the more caudal nature of spinal motor neurons compared with oculomotor neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}F). The oculomotor neurons and spinal motor neurons clustered separately based on known marker gene expression, e.g., *Phox2a*, *Phox2b*, *Tbx20*, and *Rgs4* for oculomotor neurons and *Olig1/2*, *Hb9*, and *Lhx1/3* for spinal motor neurons. Oculomotor neuron cultures were also devoid of noradrenergic neuron markers *Slc6a2* (*NET*) and *Th* ([Figure 1](#fig1){ref-type="fig"}J).

Using the top 100 differentially expressed genes (DEGs) between our *in vitro*-generated oculomotor neurons and spinal motor neurons, we could separate a published microarray dataset ([@bib26]) of *in vitro-*generated brain stem and spinal motor neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Importantly, we could also use the 100 top DEGs between our oculomotor and spinal motor neurons to separate microarray data originating from mouse oculomotor and spinal motor neurons isolated from postnatal day 7 (P7) mice ([@bib22]) ([Figure 1](#fig1){ref-type="fig"}K) and from adult rats ([@bib19]) ([Figure 1](#fig1){ref-type="fig"}L). Thus, our *in vitro*-generated motor neuron populations closely resemble their *in vivo* counterparts.

To further delineate the nature of our *in vitro* culture systems, we set out to identify gene clusters regulated in groups of samples in an unbiased way. Here we analyzed all GFP-positive (Hb9^+^ for spinal and Islet1^+^ for oculomotor) and -negative fractions from both spinal- and midbrain-specified cultures using PAGODA ([@bib12]). This analysis revealed gene sets enriched in the spinal and oculomotor cultures (GFP^+^ and GFP^−^ samples), as well as in the motor neuron groups specifically (GFP^+^) ([Figures 1](#fig1){ref-type="fig"}M and 1N; [Table S1](#mmc2){ref-type="supplementary-material"}). Of the oculomotor-enriched genes found with DESeq2, a subset was enriched in all midbrain-specified cultures (GFP^+^ and GFP^−^ cells), such as *Phox2a* and Engrailed1 (*En1*). *Fgf10*, known to be expressed in the developing midbrain, including the oculomotor nucleus ([@bib18]), and *Fgf15*, with known enrichment in midbrain and rhombomere 1 ([@bib33]), were also enriched in our midbrain-specified cultures ([Figure 1](#fig1){ref-type="fig"}M). The genes that were highly enriched specifically in oculomotor neurons (GFP^+^) included *Eya1*, *Eya2*, *Tbx20*, and *Phox2b* ([Figure 1](#fig1){ref-type="fig"}M). Vice versa, of the genes found to be differentially expressed in spinal motor neurons versus oculomotor neurons with DESeq2, a subset was enriched in all samples of the spinal-specified cultures versus the midbrain-specified cultures. This included Hox genes that regulate positional identity, e.g., *Hoxc4*, *Hoxd4*, *Hoxa5*, *Hoxb5*, *Hoxb6*, *Hoxb8*, and *Hoxd8*, as well as spinal V1 interneuron markers *Sp8* and *Prdm8*. Another subset was found to be highly specific for only the spinal motor neurons, including *Mnx1* (Hb9) and *Lhx1* ([Figure 1](#fig1){ref-type="fig"}N).

Different axon guidance-related genes are expressed by oculomotor and spinal cord motor neurons during development ([@bib4], [@bib16], [@bib37], [@bib40]). To further characterize the *in vitro*-generated oculomotor neurons, we analyzed their mRNA expression of morphological markers that are important for axon guidance. We found that oculomotor neurons were enriched in *Plxna4*, *Sema6d*, *Cdh6*, and *Cdh12*, while spinal motor neurons were enriched for *Epha3*, *Ephx4*, *Sema4a*, and *Sema5b* ([Figure S2](#mmc1){ref-type="supplementary-material"}G). We subsequently analyzed the expression level of these axon guidance RNAs in microarray data from mouse oculomotor and spinal motor neurons isolated from P7 mice ([@bib22]) and found that *Sema6d* was preferentially maintained in oculomotor postnatally ([Figure S2](#mmc1){ref-type="supplementary-material"}H).

Thus, our *in vitro-*generated oculomotor neurons have characteristics distinct from spinal motor neurons regarding genes that govern axon guidance, and some of these characteristic are maintained *in vivo*.

In conclusion, we have generated a high proportion of bona fide oculomotor neurons *in vitro* that can be utilized to understand their normal function as well as resilience to degeneration in motor neuron diseases.

Stem Cell-Derived Oculomotor Neurons Are Relatively Resistant to Excitotoxicity {#sec2.2}
-------------------------------------------------------------------------------

To investigate whether *in vitro-*generated oculomotor neurons are relatively resistant to ALS-like toxicity similarly to their *in vivo* counterparts, we used kainic acid, which is a neuroexcitatory amino acid that acts by activating glutamate receptors. Glutamate excitotoxicity is thought to be a downstream event in motor neuron degeneration in ALS and is thus considered appropriate to model this disease. First, we evaluated the mRNA levels of glutamate ionotropic receptors in our cultures to ensure that generated neurons could respond to kainic acid. mRNA-sequencing data of sorted motor neurons demonstrated that oculomotor neurons and spinal motor neurons expressed similar levels of AMPA, NMDA, and kainate receptor subunits ([Figure 2](#fig2){ref-type="fig"}A). *Grik5* (glutamate receptor, ionotrophic kainate 5) was the subunit expressed at highest level ([Figure 2](#fig2){ref-type="fig"}A) and was also detectable at the protein level in both oculomotor ([Figure 2](#fig2){ref-type="fig"}B) and spinal ([Figure 2](#fig2){ref-type="fig"}C) motor neurons. Thus, both motor neuron types should respond to kainic acid. Exposure of the cultures to kainic acid for 1 week demonstrated that oculomotor neurons were more resilient to the elicited long-term excitotoxicity than spinal motor neurons (ANOVA, ^∗^p \< 0.05; [Figures 2](#fig2){ref-type="fig"}D--2F).Figure 2*In Vitro*-Generated Oculomotor Neurons Are Relatively Resistant to ALS-like Toxicity(A) OMNs and SC MNs express similar mRNA levels of glutamate ionotropic receptor AMPA, NMDA, and kainate type subunits. The heatmap shows log~2~ RPKM values of these subunits, and no separate clustering of the two cell types is observed.(B and C) Immunohistochemistry performed on generated OMNs (B) and SC MNs (C) at D1 *in vitro* in control conditions; similar levels of glutamate ionotropic receptor kainate type subunit 5 (GRIK5) are found in both cell types. Scale bar in (C), 60 μm (applies also to B).(D and E) Microphotographs presenting SC MN (D) and OMN (E) response to kainic acid-induced toxicity (20 μM) for a week. Scale bar in (D), 100 μm (applies also to E).(F) Curves represent percentages of MN survival over time in OMN and SC MN cultures. OMNs were visualized as NF200^+^ISLET1^+^HB9^−^ cells, while SC MNs as NF200^+^ISLET1^+^HB9^+^ cells. OMNs show increased survival to kainic acid toxicity at D7 (bar and whiskers represent means ± SEM, two-way ANOVA and Tukey\'s multiple comparison test, F(9, 56) = 2.333, ^∗^p = 0.0261, SC MNs n = 4, OMNs n = 5) when compared with SC MNs (experiments were performed at least in quadruplicate, with technical replicates and with at least 130 motor neurons counted per condition in each experiment).(G) Analysis of the length of neuronal processes in both oculomotor and spinal motor neuron cultures exposed to kainic acid for 7 days showed that oculomotor neurons were unaffected by kainic acid while spinal motor neurons displayed a shortening of neurites (bar and whiskers represent means ± SEM, two-way ANOVA, ^∗^p \< 0.05, n = 4).(H--K) Sholl analysis was performed on OMN at D7 survival assay in control and KA20 conditions (H) to further assess individual MN arborization complexity during toxicity. (H) Comparison of the average number of neurite intersections of OMN in control and KA20 toxicity conditions with radial step size of 25 μm. OMNs did not show reduction in arborization (bar and whiskers represent means ± SEM, multiple t test, n = 10). (I) Example of OMN at day 7 of KA20 toxicity. Scale bar in (I), 100 μm (applies also to J). (J) Sholl mask was applied to individual OMNs after specifying the radius from the center of the soma of the neuron and created concentric circles every 25 μm of increasing radius. (K) Schematic depicting identification of neurite segments by Sholl analysis. Color code is assigned depending on arbor localization from the soma in an inside-out manner following the given radius. Multiple intersections within the same segment display the same color.

Stem cell-derived cultures are not easily temporally restricted in a precise way. Cultures that contain postmitotic neurons may also harbor neuronal progenitors that later on are specified into neurons. It can thus be challenging to distinguish survival from renewal in a stem cell-based *in vitro* system. We therefore analyzed the turnover rate in our cultures by pulsing these with bromodeoxyuridine (BrdU). Analysis of the number of BrdU^+^ISLET1/2^+^ neurons demonstrated that a significantly higher number of motor neurons were generated over time in the spinal motor neuron cultures compared with the oculomotor neuron cultures ([Figure S2](#mmc1){ref-type="supplementary-material"}I). Consequently, the resilience of oculomotor neurons should be considered even more pronounced as these cultures had a comparatively low turnover rate. Furthermore, we investigated the presence of astrocytes in the cultures and found that only a minority of cells expressed glial fibrillary acidic protein ([Figures S2](#mmc1){ref-type="supplementary-material"}J and S2K). As the processes of motor neurons show the first signs of pathology in ALS, we investigated length of neuronal processes in both oculomotor and spinal motor neuron cultures exposed to kainic acid for 7 days. The result clearly demonstrated that oculomotor neurons were unaffected by kainic acid while spinal motor neurons displayed a shortening of neurites ([Figure 2](#fig2){ref-type="fig"}G). To further evaluate oculomotor neurites, we used Sholl analysis to interrogate arborization complexity. The number and branching of oculomotor neurites were not negatively affected under kainic acid treatment ([Figures 2](#fig2){ref-type="fig"}H--2K). As axonal fragmentation and degeneration is seen early on in motor neurons in ALS, our data clearly demonstrate that oculomotor neurons cope well under conditions of excitotoxicity and maintain normal morphology.

In conclusion, *in vitro-*generated oculomotor neurons are highly resilient to ALS-like excitotoxicity. Thus, the pattern of selective motor neuron vulnerability seen *in vivo* can be replicated *in vitro*.

Oculomotor Neurons Have High Levels of Calcium-Buffering Proteins and Akt Signaling, which Could Contribute to Resilience {#sec2.3}
-------------------------------------------------------------------------------------------------------------------------

To explain the resilience of *in vitro-*generated oculomotor neurons to excitotoxicity, we conducted a directed comparative analysis of the RNA-sequencing data from purified oculomotor neurons versus spinal motor neurons. It has been suggested that preferential expression of calcium binding proteins in oculomotor neurons plays a role in their resilience ([@bib7], [@bib38]). We focused on transcripts with implications in calcium handling. Our analysis demonstrated that *Cald1*, *Esyt1*, *Camk2a*, and *Hpca11* were preferentially expressed in oculomotor neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}A). ESYT1 protein levels were also preferential to oculomotor neurons and unaffected by kainic acid treatment ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3D). This could render oculomotor neurons with an increased capacity to buffer Ca^2+^ intracellularly.

We have previously shown that AKT signaling is important in motor neuron resilience toward ALS after insulin-like growth factor-2 treatment ([@bib2]). We therefore analyzed our RNA-sequencing data from sorted oculomotor and spinal motor neurons for *Akt* signaling effectors, which could aid in explaining the relative resilience of oculomotor neurons *in vitro*. This analysis demonstrated an elevated expression of *Akt1* and *Akt3* in oculomotor neurons compared with spinal motor neurons (adjusted p \< 0.05, [Figure 3](#fig3){ref-type="fig"}A). Consistent with our RNA-sequencing findings, immunocytochemistry against pAKT and quantification of fluorescent intensities in ISLET1/2^+^ oculomotor and spinal motor neurons derived from mESCs demonstrated that oculomotor neurons had higher levels of pAKT protein than spinal motor neurons ([Figures 3](#fig3){ref-type="fig"}B--3D). These levels were maintained after excitotoxicity elicited by kainic acid (two-way ANOVA, ^∗∗∗^p \< 0.0001; [Figure 3](#fig3){ref-type="fig"}D).Figure 3mESC-Derived Oculomotor Neurons Have High Levels of Akt Signaling(A) RPKM values from RNA sequencing of mESC-derived oculomotor and spinal motor neurons enriched by FACS shows preferential expression of *Akt1* and *Akt3* transcripts in the generated OMNs (bar and whiskers represent means ± SEM, ^∗^adjusted p \< 0.05, n = 6).(B and C) Microphotographs show pAKT levels in OMN (B) and SC MN (C) cultures at D7 toxicity assay assessed by immunohistochemistry, pAKT staining alone in small insets (red channel).(D and F) Fluorescence intensities (D), analyzed in a semi-quantitative manner, indicate higher expression of pAKT in OMNs (F) (bar and whiskers represent means ± SEM, two-way ANOVA and Tukey\'s multiple comparison test, F(1, 353) = 66.1, ^∗∗∗^p \< 0.0001, n = 4). Scale bar in (F), 60 μm (applies also to B and C).(E and G) β-CATENIN expression is maintained in OMN also during kainate toxicity (E). (G) Semi-quantitative analysis of β-CATENIN over NF200 staining intensities in OMNs and SC MNs in kainate conditions (bar and whiskers represent means ± SEM, t test, t = 6.799, df = 69, ^∗∗∗^p \< 0.0001, n = 3). Scale bar in (E), 60 μm.

To further validate this pathway in oculomotor neuron resistance, we analyzed the protein levels of activated β-CATENIN (non-phosphorylated), a downstream effector of AKT signaling, using immunocytochemistry ([Figures 3](#fig3){ref-type="fig"}E and 3F). The semi-quantitative analysis demonstrated that oculomotor neurons had elevated levels of β-CATENIN compared to spinal cord motor neurons (two-way ANOVA, ^∗∗∗^p \< 0.0001; [Figure 3](#fig3){ref-type="fig"}G). β-CATENIN expression was maintained at relatively high levels in oculomotor neurons compared to spinal motor neurons also during kainate toxicity, with expression preferentially localized to processes ([Figures 3](#fig3){ref-type="fig"}F and 3G).

Our data thus indicate that AKT signaling, which is a known survival pathway, could contribute to oculomotor neuron resistance in mouse *in vivo* as well as in a dish.

AKT Signaling Is Elevated in Human Postmortem Oculomotor Neurons {#sec2.4}
----------------------------------------------------------------

To evaluate whether our *in vitro* data recapitulate motor neuron resistance in human, we used the spatial transcriptomics method LCM-seq (laser-capture microdissection coupled with RNA sequencing) ([@bib29], [@bib28]) to analyze individually isolated oculomotor neurons ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4D) and spinal motor neurons (cervical and lumbar spinal cord) ([Figures S4](#mmc1){ref-type="supplementary-material"}E--S4H) from human postmortem tissues. In addition, we isolated motor neurons from the Onuf\'s nucleus in the sacral spinal cord ([Figures S4](#mmc1){ref-type="supplementary-material"}I--S4L and [Table S2](#mmc3){ref-type="supplementary-material"}), as these are highly resilient to degeneration in ALS and maintained until end stage of disease ([@bib25]), similar to oculomotor neurons. Analysis of marker gene expression showed that all motor neuron groups expressed high levels of neurofilaments and *VACHT* (*SLC18A3*) ([Figure S4](#mmc1){ref-type="supplementary-material"}M). Motor neurons also expressed *ISL1/2* and *ChAT*, while being almost devoid of contaminating glial markers, e.g., *SLC1A3*, *AQP4*, *CCL3*, *AIF1*, *SOX10*, and *MOG* ([Figure S4](#mmc1){ref-type="supplementary-material"}M). Analysis of the *PHOX2A/B* and *HOX* gene code expression clearly clustered oculomotor neurons away from all spinal motor neuron groups ([Figure S4](#mmc1){ref-type="supplementary-material"}N). PCA of all expressed genes separated oculomotor neurons and spinal motor neurons along PC2, while Onuf\'s nucleus motor neurons separated out on PC3 ([Figure 4](#fig4){ref-type="fig"}A). Analysis of the *PI3K-AKT* signaling pathway ([Figure S4](#mmc1){ref-type="supplementary-material"}O) demonstrated that *AKT3* was elevated in human oculomotor neurons (adjusted p \< 0.05, [Figure 4](#fig4){ref-type="fig"}B), similar to mESC-derived oculomotor neurons ([Figure 3](#fig3){ref-type="fig"}A). To analyze whether oculomotor and Onuf\'s motor neurons shared gene expression that was distinct from other spinal motor neurons (cervical and lumbar), we analyzed DEGs of oculomotor versus spinal and Onuf\'s versus spinal ([Table S3](#mmc4){ref-type="supplementary-material"}). This analysis showed that the majority of DEGs were unique to each cell type, with 1,025 DEGs unique to oculomotor (553 up- and 472 downregulated compared to other spinal motor neurons) and 921 DEGs unique to Onuf\'s motor neurons (349 up- and 572 downregulated compared to other spinal motor neurons) ([Figure 4](#fig4){ref-type="fig"}C and [Table S3](#mmc4){ref-type="supplementary-material"}). High *AKT3* levels were unique to oculomotor neurons. Elevated *PVALB* (parvalbumin) and *GABRA1* levels were also unique to oculomotor neurons ([Figure 4](#fig4){ref-type="fig"}C), consistent with previous findings ([@bib6], [@bib7], [@bib19]). Oculomotor and Onuf\'s shared 214 DEGs, of which 58 were upregulated and 142 downregulated compared to other spinal motor neurons, and 14 of which were regulated in the opposite direction in the two nuclei ([Figure 4](#fig4){ref-type="fig"}C and [Table S3](#mmc4){ref-type="supplementary-material"}). *MIF* (macrophage migration inhibitory factor), which is neuroprotective in ALS ([@bib36]), showed shared elevated expression in both oculomotor and Onuf\'s motor neurons ([Figure 4](#fig4){ref-type="fig"}C). Gene ontology (GO)-term analysis of the identified DEGs revealed a number of GO terms that were upregulated in oculomotor neurons versus the other motor neuron groups, including gluconeogenesis, regulation of membrane potential, anterograde transsynaptic signaling, cation transmembrane transport, neurodevelopment, neuron differentiation, and CNS development ([Figure 4](#fig4){ref-type="fig"}D and [Table S4](#mmc5){ref-type="supplementary-material"}). Analysis of GO terms enriched in Onuf\'s motor neurons included synaptic signaling, anterograde, transsynaptic signaling, NAD biosynthetic process, ATP biosynthetic process, regulated exocytosis, regulation of neurotransmitter levels, and synaptic vesicle localization ([Figure 4](#fig4){ref-type="fig"}E and [Table S4](#mmc5){ref-type="supplementary-material"}).Figure 4Human Oculomotor Neurons Show a Transcriptional Profile, with Elevated *AKT3*, Unique from Onuf\'s Nucleus Motor Neurons(A) PCA of all expressed genes separated into Onuf\'s, oculomotor (OMN), and spinal (cervical and lumbar) (SC_MN) motor neuron groups.(B) RNA-sequencing data showed that *AKT3* was elevated in OMNs compared to the other motor neuron groups (^∗^adjusted p \< 0.05, OMN n = 8, SC_MN n = 12, Onuf\'s n = 3, bar and whiskers represent means ± SEM).(C) To distinguish the number of DEGs that were shared or unique to each resistant neuron group compared to vulnerable spinal motor neurons, we analyzed DEGs between OMN and SC_MN and between Onuf\'s and SC_MN. This analysis showed that the majority of DEGs were unique to each resistant motor neuron group, with OMNs showing 553 upregulated and 472 downregulated unique DEGs and Onuf\'s motor neurons showing 349 upregulated and 572 downregulated unique DEGs. Oculomotor and Onuf\'s shared 58 upregulated and 142 downregulated DEGs compared with vulnerable spinal motor neurons. ^∗^14 DEGs were regulated in the opposite direction in the two motor nuclei.

In conclusion, our data indicate that *AKT* signaling is elevated also in adult human oculomotor neurons and may in part underlie their resilience to degeneration in ALS. Notably, while oculomotor and Onuf\'s nucleus motor neurons mainly show distinct gene regulation, we also identified common pathways that may underlie their joint resilience.

Discussion {#sec3}
==========

In ALS, motor neuron subpopulations show differential vulnerability to degeneration. In particular, cranial motor neurons of the oculomotor, trochlear, and abducens nuclei (cranial nerves 3, 4, and 6), which innervate the extraocular muscles around the eyes, are highly resistant throughout disease progression. In our study we demonstrate that a high proportion of bona fide oculomotor neurons can be generated from mESCs through temporal overexpression of PHOX2A, and that these are relatively resilient to ALS-like toxicity.

Oculomotor neurons are generated in the ventral midbrain through the specification by SHH (secreted from the floor plate and the notochord), FGF8, and WNTs (both secreted by and around the isthmic organizer). These morphogens in turn regulate transcription factors that influence differentiation of ventral midbrain neurons, including oculomotor neurons, dopamine neurons, red nucleus neurons, and GABA-positive interneurons (reviewed in [@bib30]). Oculomotor neurons are specified by the transcription factors PHOX2A, PHOX2B, and LMX1B ([@bib9], [@bib34]). PHOX2A is required to drive oculomotor neuron fate as demonstrated by the lack of both oculomotor and trochlear nuclei in *Phox2a* knockout mice ([@bib34]). PHOX2A is also sufficient to generate a complete oculomotor complex as shown by studies in chick ([@bib17], [@bib34]). PHOX2B, on the other hand, is sufficient to induce ectopic generation of oculomotor neurons in the spinal cord, but is not required to induce oculomotor neuron specification in the midbrain ([@bib11], [@bib34]). *In vitro* studies have shown that (1) mESCs can be directly programmed into cranial neurons using the proneuronal gene *Ngn2*, in combination with *Islet1* and *Phox2a* ([@bib26]), and (2) overexpression of either PHOX2A or PHOX2B alone in mESC-derived neural progenitors exposed to SHH and FGF8 can promote a midbrain/hindbrain motor neuron fate ([@bib27]). However, while it was demonstrated that cranial motor neurons were generated *in vitro* it was never previously determined whether oculomotor neurons were specifically produced.

Here, we show that PHOX2A overexpression in neural progenitors in combination with patterning using FGF8 and SHH resulted in the generation of 50% ISLET^+^ neurons of which more than half were PHOX2A^+^. The transcriptome and proteome of oculomotor neurons is distinct from other motor neurons (reviewed in [@bib30]). Notably, oculomotor neurons can be distinguished by their lack of the transcription factor HB9, which defines other somatic motor neurons ([@bib15], [@bib24]). As the vast majority of ISLET^+^ cells in our midbrain cultures lacked HB9, we conclude that the PHOX2A^+^ cells generated were indeed oculomotor neurons and that *Phox2a* overexpression is sufficient to induce an oculomotor fate from stem cells *in vitro*. This conclusion was further supported by our RNA-sequencing experiments on purified oculomotor and spinal motor neuron cultures and our bioinformatics cross-comparison with other *in vitro* and *in vivo* datasets from rodent and man ([@bib6], [@bib19], [@bib22]), which confirmed that the oculomotor neurons we generated were molecularly similar to their *in vivo* counterpart. Furthermore, our analysis of axon guidance molecules demonstrated differential expression of distinct morphological markers in oculomotor and spinal motor neurons. Finally, the electrical properties of the mESC-derived motor neurons matured over time in culture, and cells also expressed the cholinergic marker ChAT. Altogether this demonstrates that we can generate bona fide oculomotor neurons.

Furthermore, we found that mRNAs of *Fgf10* and *Fgf15* were enriched in our oculomotor cultures. These two morphogens are normally expressed in the developing midbrain, and *Fgf10* is even present within oculomotor neurons themselves ([@bib18], [@bib33]). It is therefore highly conceivable that these factors are involved in further specifying the cultures. We therefore believe that these factors can be used to further improve the *in vitro* differentiation protocol, but this remains to be further investigated.

Multiple studies have demonstrated that differential motor neuron vulnerability appears to be regulated by cell-intrinsic differences in gene expression ([@bib2], [@bib6], [@bib19], [@bib22]). We therefore hypothesized that *in vitro-*generated oculomotor neurons would be more resilient to ALS-like toxicity than spinal motor neurons. Indeed, our experiments on neuronal vulnerability clearly demonstrated that oculomotor neurons were more resistant to the ALS-like toxicity elicited by kainic acid than spinal motor neurons. Furthermore, the fact that oculomotor neuron processes remained intact indicates that these cells were indeed highly resilient, as axonal degeneration is an early sign of pathology in ALS.

It has been shown that oculomotor neurons have a higher calcium-buffering capacity than other motor neuron groups ([@bib39]), which could render the cells more resilient to excitotoxic insults. Our finding that several transcripts with implications for calcium handling were preferentially expressed in stem cell-derived oculomotor neurons as well as oculomotor neurons in man were thus very compelling and consistent with their resilience. ESYT1, for example, is an ER integral membrane protein that presents a cytosolic synaptotagmin-like domain that can bind organelle membranes and a C2 domain able to bind the plasma membrane. These interactions are involved in exchange of lipids and vesicles but also, in the ER, control of Ca^2+^ homeostasis. Thus, ER-plasma membrane junctions can control Ca^2+^ release from ER in response to extracellular Ca^2+^ levels ([@bib13]), an event that could have a beneficial effect during excitotoxicity.

Furthermore, we have previously shown that AKT signaling plays an important role in induced resistance in vulnerable motor neurons ([@bib2]). We now demonstrate that *Akt* signaling is more highly activated in resistant oculomotor neurons *in vitro* as well as *in vivo* in human oculomotor neurons. This observation indicates that oculomotor neurons preferentially activate a cell-intrinsic survival program. Notably, cross-comparison of human oculomotor neurons with resilient human Onuf\'s nucleus motor neurons showed that elevated *AKT* signaling was unique to oculomotor neurons. When comparing human oculomotor and Onuf\'s motor neurons with vulnerable spinal motor neurons it became evident that the majority of DEGs were unique to each resilient nucleus. However, there were commonly regulated genes across these two resilient nuclei, including *MIF*. MIF was recently shown to inhibit the toxicity of misfolded SOD1 ([@bib36]), indicating that these two neuron groups may be better at handling toxic aggregation-prone proteins.

In conclusion, we have demonstrated that bona fide oculomotor neurons can be generated from stem cells *in vitro*. We also show that these neurons are relatively resilient to ALS-like toxicity. This finding enables modeling of neuronal resistance and susceptibility in ALS *in vitro*, which could further elucidate mechanisms that could be highly advantageous to activate *in vivo* to rescue vulnerable motor neurons from degeneration.

Experimental Procedures {#sec4}
=======================

Ethics Statement {#sec4.1}
----------------

All work was carried out according to the Code of Ethics of the World Medical Association (Declaration of Helsinki) and with national legislation and institutional guidelines. Animal procedures were approved by the Swedish animal ethics review board (Stockholm Norra Djurförsöksetiska Nämnd). Ethical approval for the use of the human post mortem samples was obtained from the regional ethical review board in Stockholm, Sweden (Regionala Etikprövningsnämnden, Stockholm, EPN). Human CNS samples were obtained from the Netherlands Brain Bank ([www.brainbank.nl](http://www.brainbank.nl){#intref0010}), the National Disease Research Interchange ([www.ndriresource.org](http://www.ndriresource.org){#intref0015}), and the NIH Neurobiobank with the written informed consent from the donors or next of kin.

Generation of mESC Lines and Specification into Oculomotor and Spinal Motor Neurons {#sec4.2}
-----------------------------------------------------------------------------------

Three different mESC lines were used in this study: E14.1 (ATCC), *Hb9*-GFP (gift from Dr. S. Thams, Karolinska Institutet), and *Islet1*-GFP (gift from Prof. S. Pfaff, UCSD). To increase oculomotor neuron differentiation efficiency, we generated E14.1/*NesEPhox2a* and *Islet1*-GFP/*NesEPhox2a* mESC lines by Lipofectamine (Invitrogen) transfection. *NesEPhox2a* construct was a gift from Prof. J. Ericson (Karolinska Institutet). As the nestin enhancer was used for overexpression, transgene overexpression is limited to neuronal progenitors. Specification of mESCs into spinal motor neurons was conducted by exposing embryo bodies (EBs) to the smoothened agonist SAG (500 nM, Calbiochem \#364590-63-6) and retinoic acid (100 nM, Calbiochem \#302-79-4) for 5 days, while oculomotor neurons were patterned by SAG (250 nM) and FGF8 (100 ng/mL, R&D Systems \#423-F8) for 5 days. Medium containing morphogens was replaced daily. EB dissociation and motor neuron culture maintenance were carried out as previously described ([@bib41]). Oculomotor neurons and spinal motor neurons were kept in Neurobasal medium + Glutamax (Gibco) with a cocktail of trophic factors (5 ng/mL each of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, neurotrophin-3, and ciliary neurotrophic factor). All cultures, including survival experiments, were treated with the mitotic inhibitor 5-fluoro-2′-deoxyuridine (final concentration 2 μM) to reduce cell proliferation.

Fluorescent-Activated Cell Sorting and RNA Sequencing of Stem Cell-Derived Neurons {#sec4.3}
----------------------------------------------------------------------------------

*Islet1*-GFP/*NesEPhox2a* and *Hb9*-GFP ESCs were differentiated into oculomotor and spinal motor neurons, respectively. GFP^+^ motor neurons were sorted, and positive and negative fractions were collected for mRNA sequencing or plated for subsequent immunocytochemistry analysis. FACS was performed using a 100-μm nozzle, a sheath pressure of 15--25 pounds per square inch and an acquisition rate of 1,000--2,000 events per second ([@bib20]). 5 × 10^3^ cells were collected in 5% Triton X-100 (Sigma-Aldrich) in water and then prepared for RNA-seq as previously described ([@bib29]). Samples were sequenced on Illumina HiSeq2000 and HiSeq2500 platforms with read lengths of 43 and 51 bp, respectively.

Laser-Capture Microdissection and RNA Sequencing of Human Motor Neurons {#sec4.4}
-----------------------------------------------------------------------

LCM-seq of motor neurons from human postmortem tissues was performed as previously described ([@bib29], [@bib28]).

RNA-Seq Data Processing {#sec4.5}
-----------------------

Reads from cell-culture samples were mapped to the mouse mm10 reference genome with HISAT2 ([@bib23]) using the publicly available infrastructure (available at [usegalaxy.org](http://usegalaxy.org){#intref0020}) on the main Galaxy server ([@bib1]). Human LCM samples were mapped to hg38/GRCh38 (Gencode version V29) using STAR version 2.5.3 ([@bib10]). Transcript-level counts and RPKM values were obtained using rpkmforgenes.py ([@bib35]). After mapping, the basic exclusion criteria were \<500,000 mapped reads and, for LCM samples, lack of both motor neuron marker transcripts ISL1 and ChAT.

ALS-like Toxicity and Motor Neuron Survival {#sec4.6}
-------------------------------------------

Oculomotor and spinal motor neurons were cultured for 5 days and then exposed to kainic acid. Three concentrations of kainic acid were tested: 20, 50, and 100 μM. A concentration of 20 μM was found sufficient to induce consistent motor neuron death also when motor neurons were cultured on astrocytes. Kainate toxicity was induced for 7 days. Quantifications were performed blind to the motor neuron population and toxicity condition. Pictures were taken with a Zeiss LSM700 confocal microscope (40× magnification and 1.5 digital zoom) using the ZEN 2010S SP1 software and then further analyzed by ImageJ software. At least four experiments per condition were quantified in technical duplicates. Twelve random areas were quantified per each coverslip (at least 130 cells were quantified for each condition). To evaluate proliferation and generation of motor neurons, we exposed cultures to pulses of BrdU (Sigma \#B5002) for 24 h. BrdU was dissolved in dimethyl sulfoxide (DMSO; Sigma \#276855) and added to the cultures at a final concentration of 10 μM. After 24 h of exposure to BrdU, cells were washed twice with fresh culture medium. Proliferation was assessed at day 0 (D0), day 2 (D2), and day 3 (D3) of the survival protocol and all samples were fixed with 4% paraformaldehyde at day 7 (D7). Quantifications were performed in triplicates with technical duplicates.

Morphological Analysis {#sec4.7}
----------------------

Arborization and Sholl analysis were conducted utilizing Fiji software. To compare arborization area of oculomotor neurons and spinal motor neurons, we transformed the microphotographs to a grayscale 8-bit image, and assessed quantification after applying a threshold for signal intensity/background correction. Threshold values were kept constant among images, and microphotographs with higher background noise were excluded. Between 10 and 12 pictures per condition per experiment were quantified. Experiments were performed in quadruplicates. The complexity of oculomotor neuron arborization after kainic acid toxicity was obtained by Sholl analysis ([@bib32]) by calculating the average of neurites intersecting defined concentric cycles spaced 25 μm from each other starting from the center of the cell body as a function of distance from soma. Individual oculomotor neurons were analyzed after culturing them at lower density (spinal motor neuron analysis could not be performed due to their poor survival at lower densities). Several microphotographs were taken at 40× magnification with a Zeiss LSM700 confocal microscope, mounted with Adobe Photoshop software, and analyzed with Fiji software. The intersection averages were analyzed by multiple t test.

Statistical Analysis {#sec4.8}
--------------------

All statistical analyses were performed with GraphPad software unless otherwise specified. Two-way ANOVA was used when taking into account multiple variables and making multiple comparisons, followed by appropriate post hoc analysis. Unpaired Student\'s t test was used to compare two groups. Further details on statistical tests used can be found in figure legends as well as information on the total number of motor neurons counted per experiment. All experiments were performed at least in triplicate with technical duplicates. All results are expressed as mean ± SEM unless otherwise specified.
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